1.Farr, J. N.; Khosla, S. Cellular senescence in bone. Bone. 2019, 121, 121-133.  
2. Metavarayuth, K.; Villarreal, E.; Wang, H.; Wang, Q. Surface topography and free energy regulate osteogenesis of stem cells: effects of shape-controlled gold nanoparticles. Biomater Transl. 2021, 2, 165-173.  
3. Wang, T.; Huang, S.; He, C. Senescent cells: a therapeutic target for osteoporosis. Cell Prolif. 2022, 55, e13323.  

4. Brown, C. Osteoporosis: staying strong. Nature. 2017, 550, S15-S17.  
5. Coryell, P. R.; Diekman, B. O.; Loeser, R. F. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021, 17, 47-57.  
6. Loeser, R. F.; Collins, J. A.; Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016, 12, 412-420.  
7. Yuan, J.; Maturavongsadit, P.; Zhou, Z.; Lv, B.; Lin, Y.; Yang, J.; Luckanagul, J. A. Hyaluronic acid-based hydrogels with tobacco mosaic virus containing cell adhesive peptide induce bone repair in normal and osteoporotic rats. Biomater Transl. 2020, 1, 89-98.  
8. Day, R. O.; Graham, G. G. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ. 2013, 346, f3195.  
9. Katz, J. N.; Arant, K. R.; Loeser, R. F. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021, 325, 568-578.  
10. Arora, D.; Robey, P. G. Recent updates on the biological basis of heterogeneity in bone marrow stromal cells/skeletal stem cells. Biomater Transl. 2022, 3, 3-16.  
11. Liu, H.; Zhang, H.; Wang, S.; Cui, J.; Weng, W.; Liu, X.; Tang, H.; Hu, Y.; Li, X.; Zhang, K.; Zhou, F.; Jing, Y.; Su, J. Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis. Compos B Eng. 2023, 255, 110610.  
12. Liu, H.; Li, M.; Zhang, T.; Liu, X.; Zhang, H.; Geng, Z.; Su, J. Engineered bacterial extracellular vesicles for osteoporosis therapy. Chem Eng J. 2022, 450, 138309.  
13. Liu, H.; Geng, Z.; Su, J. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy. Extracell Vesicles Circ Nucleic Acids. 2022, 3, 63-86.  
14. Liu, H.; Zhang, H.; Han, Y.; Hu, Y.; Geng, Z.; Su, J. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy. Theranostics. 2022, 12, 6576-6594.  
15. Guo, J.; Wang, F.; Hu, Y.; Luo, Y.; Wei, Y.; Xu, K.; Zhang, H.; Liu, H.; Bo, L.; Lv, S.; Sheng, S.; Zhuang, X.; Zhang, T.; Xu, C.; Chen, X.; Su, J. Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Rep Med. 2023, 4, 100881.  
16. Song, H.; Li, X.; Zhao, Z.; Qian, J.; Wang, Y.; Cui, J.; Weng, W.; Cao, L.; Chen, X.; Hu, Y.; Su, J. Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett. 2019, 19, 3040-3048.  
17. Wang, J.; Li, X.; Wang, S.; Cui, J.; Ren, X.; Su, J. Bone-targeted exosomes: strategies and applications. Adv Healthc Mater. 2023, 12, e2203361.  
18. Pang, L.; Jin, H.; Lu, Z.; Xie, F.; Shen, H.; Li, X.; Zhang, X.; Jiang, X.; Wu, L.; Zhang, M.; Zhang, T.; Zhai, Y.; Zhang, Y.; Guan, H.; Su, J.; Li, M.; Gao, J. Treatment with mesenchymal stem cell-derived nanovesicle-containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization. Adv Healthc Mater. 2023, 12, e2300315.  
19. Liu, H.; Zhang, Q.; Wang, S.; Weng, W.; Jing, Y.; Su, J. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: Advances and perspectives. Bioact Mater. 2022, 14, 169-181.  
20. Wang, Z. X.; Luo, Z. W.; Li, F. X.; Cao, J.; Rao, S. S.; Liu, Y. W.; Wang, Y. Y.; Zhu, G. Q.; Gong, J. S.; Zou, J. T.; Wang, Q.; Tan, Y. J.; Zhang, Y.; Hu, Y.; Li, Y. Y.; Yin, H.; Wang, X. K.; He, Z. H.; Ren, L.; Liu, Z. Z.; Hu, X. K.; Yuan, L. Q.; Xu, R.; Chen, C. Y.; Xie, H. Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox. Nat Commun. 2022, 13, 1453.  
21. Jiang, Y.; Li, J.; Xue, X.; Yin, Z.; Xu, K.; Su, J. Engineered extracellular vesicles for bone therapy. Nano Today. 2022, 44, 101487.  
22. Liu, J. H.; Yue, T.; Luo, Z. W.; Cao, J.; Yan, Z. Q.; Jin, L.; Wan, T. F.; Shuai, C. J.; Wang, Z. G.; Zhou, Y.; Xu, R.; Xie, H. Akkermansia muciniphila promotes type H vessel formation and bone fracture healing by reducing gut permeability and inflammation. Dis Model Mech. 2020, 13, dmm043620.  
23. Shan, S. K.; Lin, X.; Li, F.; Xu, F.; Zhong, J. Y.; Guo, B.; Wang, Y.; Zheng, M. H.; Wu, F.; Yuan, L. Q. Exosomes and bone disease. Curr Pharm Des. 2019, 25, 4536-4549.  
24. Mi, B.; Chen, L.; Xiong, Y.; Yang, Y.; Panayi, A. C.; Xue, H.; Hu, Y.; Yan, C.; Hu, L.; Xie, X.; Lin, Z.; Zhou, W.; Cao, F.; Xiao, X.; Feng, Q.; Liu, G. Osteoblast/osteoclast and immune cocktail therapy of an exosome/drug delivery multifunctional hydrogel accelerates fracture repair. ACS Nano. 2022, 16, 771-782.  
25. Zeng, Z. L.; Xie, H. Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review. Biomater Transl. 2022, 3, 175-187.  
26. Chen, S.; Chen, X.; Geng, Z.; Su, J. The horizon of bone organoid: a perspective on construction and application. Bioact Mater. 2022, 18, 15-25.  
27. Keshara, R.; Kim, Y. H.; Grapin-Botton, A. Organoid imaging: seeing development and function. Annu Rev Cell Dev Biol. 2022, 38, 447-466.  
28. Liu, H.; Sun, J.; Wang, M.; Wang, S.; Su, J.; Xu, C. Intestinal organoids and organoids extracellular vesicles for inflammatory bowel disease treatment. Chem Eng J. 2023, 465, 142842.  
29. Liu, H.; Su, J. Organoid and organoid extracellular vesicles for osteoporotic fractures therapy: current status and future perspectives. Interdiscip Med. 2023, 1, e20230011.  
30. Bock, C.; Boutros, M.; Camp, J. G.; Clarke, L.; Clevers, H.; Knoblich, J. A.; Liberali, P.; Regev, A.; Rios, A. C.; Stegle, O.; Stunnenberg, H. G.; Teichmann, S. A.; Treutlein, B.; Vries, R. G. J.; Human cell atlas ‘biological network’ organoids. The organoid cell atlas. Nat Biotechnol. 2021, 39, 13-17.  
31. Garreta, E.; Kamm, R. D.; Chuva de Sousa Lopes, S. M.; Lancaster, M. A.; Weiss, R.; Trepat, X.; Hyun, I.; Montserrat, N. Rethinking organoid technology through bioengineering. Nat Mater. 2021, 20, 145-155.  
32. Brandenberg, N.; Hoehnel, S.; Kuttler, F.; Homicsko, K.; Ceroni, C.; Ringel, T.; Gjorevski, N.; Schwank, G.; Coukos, G.; Turcatti, G.; Lutolf, M. P. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays. Nat Biomed Eng. 2020, 4, 863-874.  
33. Lancaster, M. A.; Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014, 345, 1247125.  
34. Zha, Q. B.; Yao, Y. F.; Ren, Z. J.; Li, X. J.; Tang, J. H. Extracellular vesicles: an overview of biogenesis, function, and role in breast cancer. Tumour Biol. 2017, 39, 1010428317691182.  
35. van Niel, G.; D’Angelo, G.; Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018, 19, 213-228.  
36. Mathieu, M.; Martin-Jaular, L.; Lavieu, G.; Théry, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019, 21, 9-17.  
37. Jin, S.; Wang, Y.; Wu, X.; Li, Z.; Zhu, L.; Niu, Y.; Zhou, Y.; Liu, Y. Young exosome bio-nanoparticles restore aging-impaired tendon stem/progenitor cell function and reparative capacity. Adv Mater. 2023, 35, e2211602.  
38. Record, M.; Carayon, K.; Poirot, M.; Silvente-Poirot, S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014, 1841, 108120.  
39. Nguyen, A.; Yaffe, M. B. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med. 2003, 31, S1-6.  
40. Murphy, D. E.; de Jong, O. G.; Brouwer, M.; Wood, M. J.; Lavieu, G.; Schiffelers, R. M.; Vader, P. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med. 2019, 51, 1-12.  
41. Pegtel, D. M.; Gould, S. J. Exosomes. Annu Rev Biochem. 2019, 88, 487-514.  
42. Zhang, Q.; Wang, L.; Wang, S.; Cheng, H.; Xu, L.; Pei, G.; Wang, Y.; Fu, C.; Jiang, Y.; He, C.; Wei, Q. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022, 7, 78.  
43. Zhong, L.; Liao, D.; Li, J.; Liu, W.; Wang, J.; Zeng, C.; Wang, X.; Cao, Z.; Zhang, R.; Li, M.; Jiang, K.; Zeng, Y. X.; Sui, J.; Kang, T. Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. Signal Transduct Target Ther. 2021, 6, 59.  
44. Dutta, D.; Heo, I.; Clevers, H. Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med. 2017, 23, 393-410.  
45. Shao, H.; Im, H.; Castro, C. M.; Breakefield, X.; Weissleder, R.; Lee, H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018, 118, 1917-1950.  
46. Rong, Y.; Wang, Z.; Tang, P.; Wang, J.; Ji, C.; Chang, J.; Zhu, Y.; Ye, W.; Bai, J.; Liu, W.; Yin, G.; Yu, L.; Zhou, X.; Cai, W. Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury. Bioact Mater. 2023, 23, 328-342.  
47. Zhang, Q.; Jeppesen, D. K.; Higginbotham, J. N.; Franklin, J. L.; Coffey, R. J. Comprehensive isolation of extracellular vesicles and nanoparticles. Nat Protoc. 2023, 18, 1462-1487.  
48. Lai, J. J.; Chau, Z. L.; Chen, S. Y.; Hill, J. J.; Korpany, K. V.; Liang, N. W.; Lin, L. H.; Lin, Y. H.; Liu, J. K.; Liu, Y. C.; Lunde, R.; Shen, W. T. Exosome processing and characterization approaches for research and technology development. Adv Sci (Weinh). 2022, 9, e2103222.  
49. Takov, K.; Yellon, D. M.; Davidson, S. M. Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential. J Extracell Vesicles. 2019, 8, 1560809.  

50. Chattrairat, K.; Yasui, T.; Suzuki, S.; Natsume, A.; Nagashima, K.; Iida, M.; Zhang, M.; Shimada, T.; Kato, A.; Aoki, K.; Ohka, F.; Yamazaki, S.; Yanagida, T.; Baba, Y. All-in-one nanowire assay system for capture and analysis of extracellular vesicles from an ex vivo brain tumor model. ACS Nano. 2023, 17, 2235-2244.  
51. Dong, L.; Zieren, R. C.; Horie, K.; Kim, C. J.; Mallick, E.; Jing, Y.; Feng, M.; Kuczler, M. D.; Green, J.; Amend, S. R.; Witwer, K. W.; de Reijke, T. M.; Cho, Y. K.; Pienta, K. J.; Xue, W. Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium. J Extracell Vesicles. 2020, 10, e12044.  
52. Foers, A. D.; Chatfield, S.; Dagley, L. F.; Scicluna, B. J.; Webb, A. I.; Cheng, L.; Hill, A. F.; Wicks, I. P.; Pang, K. C. Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography. J Extracell Vesicles. 2018, 7, 1490145.  
53. Hu, Y.; Li, X.; Zhang, Q.; Gu, Z.; Luo, Y.; Guo, J.; Wang, X.; Jing, Y.; Chen, X.; Su, J. Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss. Bioact Mater. 2021, 6, 2905-2913.  
54. Xu, X.; Liang, Y.; Li, X.; Ouyang, K.; Wang, M.; Cao, T.; Li, W.; Liu, J.; Xiong, J.; Li, B.; Xia, J.; Wang, D.; Duan, L. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021, 269, 120539.  
55. Szvicsek, Z.; Oszvald, Á.; Szabó, L.; Sándor, G. O.; Kelemen, A.; Soós, A.; Pálóczi, K.; Harsányi, L.; Tölgyes, T.; Dede, K.; Bursics, A.; Buzás, E. I.; Zeöld, A.; Wiener, Z. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors. Cell Mol Life Sci. 2019, 76, 2463-2476.  
56. Abdollahi, S. Extracellular vesicles from organoids and 3D culture systems. Biotechnol Bioeng. 2021, 118, 1029-1049.  
57. Wu, W.; Zhou, W.; Jiang, J.; Wang, M.; Zhang, J.; Yang, J.; Tang, Q.; Liu, H.; Liu, D.; Xu, W.; Zhong, J. L.; Yang, L.; Lei, M. Mechanical stimuli-induced CCL2 restores adult mouse cells to regenerate hair follicles. Mol Ther Nucleic Acids. 2023, 32, 94-110.  
58. Rocha, S.; Carvalho, J.; Oliveira, P.; Voglstaetter, M.; Schvartz, D.; Thomsen, A. R.; Walter, N.; Khanduri, R.; Sanchez, J. C.; Keller, A.; Oliveira, C.; Nazarenko, I. 3D cellular architecture affects microrna and protein cargo of extracellular vesicles. Adv Sci (Weinh). 2019, 6, 1800948.  
59. Yuan, X.; Sun, L.; Jeske, R.; Nkosi, D.; York, S. B.; Liu, Y.; Grant, S. C.; Meckes, D. G., Jr.; Li, Y. Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. J Extracell Vesicles. 2022, 11, e12235.  
60. Liu, C.; Chen, X.; Liu, Y.; Sun, L.; Yu, Z.; Ren, Y.; Zeng, C.; Li, Y. Engineering extracellular matrix-bound nanovesicles secreted by three-dimensional human mesenchymal stem cells. Adv Healthc Mater. 2023, 12, e2301112.  
61. Zhang, Y.; Chopp, M.; Zhang, Z. G.; Katakowski, M.; Xin, H.; Qu, C.; Ali, M.; Mahmood, A.; Xiong, Y. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int. 2017, 111, 69-81.  
62. Jalilian, E.; Massoumi, H.; Bigit, B.; Amin, S.; Katz, E. A.; Guaiquil, V. H.; Anwar, K. N.; Hematti, P.; Rosenblatt, M. I.; Djalilian, A. R. Bone marrow mesenchymal stromal cells in a 3D system produce higher concentration of extracellular vesicles (EVs) with increased complexity and enhanced neuronal growth properties. Stem Cell Res Ther. 2022, 13, 425.  
63. Ural, E. E.; Toomajian, V.; Hoque Apu, E.; Veletic, M.; Balasingham, I.; Ashammakhi, N.; Kanada, M.; Contag, C. H. Visualizing extracellular vesicles and their function in 3D tumor microenvironment models. Int J Mol Sci. 2021, 22, 4784.  
64. He, C.; Zheng, S.; Luo, Y.; Wang, B. Exosome theranostics: biology and translational medicine. Theranostics. 2018, 8, 237-255.  
65. Yang, B.; Chen, Y.; Shi, J. Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater. 2019, 31, e1802896.  
66. Cully, M. Exosome-based candidates move into the clinic. Nat Rev Drug Discov. 2021, 20, 6-7.  
67. Zinger, A.; Cvetkovic, C.; Sushnitha, M.; Naoi, T.; Baudo, G.; Anderson, M.; Shetty, A.; Basu, N.; Covello, J.; Tasciotti, E.; Amit, M.; Xie, T.; Taraballi, F.; Krencik, R. Humanized biomimetic nanovesicles for neuron targeting. Adv Sci (Weinh). 2021, 8, e2101437.  
68. Tauro, B. J.; Greening, D. W.; Mathias, R. A.; Mathivanan, S.; Ji, H.; Simpson, R. J. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics. 2013, 12, 587-598.  
69. Jurj, A.; Pasca, S.; Braicu, C.; Rusu, I.; Korban, S. S.; Berindan-Neagoe, I. Focus on organoids: cooperation and interconnection with extracellular vesicles - Is this the future of in vitro modeling? Semin Cancer Biol. 2022, 86, 367-381.  
70. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J. J.; Lötvall, J. O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007, 9, 654-659.  
71. Théry, C.; Duban, L.; Segura, E.; Véron, P.; Lantz, O.; Amigorena, S. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 2002, 3, 1156-1162.  
72. Zhang, Y.; Yan, Y.; Meng, J.; Girotra, M.; Ramakrishnan, S.; Roy, S. Immune modulation mediated by extracellular vesicles of intestinal organoids is disrupted by opioids. Mucosal Immunol. 2021, 14, 887-898.  
73. Roush, S.; Slack, F. J. The let-7 family of microRNAs. Trends Cell Biol. 2008, 18, 505-516.  
74. Lee, H.; Han, S.; Kwon, C. S.; Lee, D. Biogenesis and regulation of the let-7 miRNAs and their functional implications. Protein Cell. 2016, 7, 100-113.  

75. Watanabe, S.; Kobayashi, S.; Ogasawara, N.; Okamoto, R.; Nakamura, T.; Watanabe, M.; Jensen, K. B.; Yui, S. Transplantation of intestinal organoids into a mouse model of colitis. Nat Protoc. 2022, 17, 649-671.  
76. Vissink, A.; Mitchell, J. B.; Baum, B. J.; Limesand, K. H.; Jensen, S. B.; Fox, P. C.; Elting, L. S.; Langendijk, J. A.; Coppes, R. P.; Reyland, M. E. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys. 2010, 78, 983-991.  
77. Sun, B. K.; Siprashvili, Z.; Khavari, P. A. Advances in skin grafting and treatment of cutaneous wounds. Science. 2014, 346, 941-945.  
78. Adine, C.; Ng, K. K.; Rungarunlert, S.; Souza, G. R.; Ferreira, J. N. Engineering innervated secretory epithelial organoids by magnetic three-dimensional bioprinting for stimulating epithelial growth in salivary glands. Biomaterials. 2018, 180, 52-66.  
79. Chansaenroj, A.; Adine, C.; Charoenlappanit, S.; Roytrakul, S.; Sariya, L.; Osathanon, T.; Rungarunlert, S.; Urkasemsin, G.; Chaisuparat, R.; Yodmuang, S.; Souza, G. R.; Ferreira, J. N. Magnetic bioassembly platforms towards the generation of extracellular vesicles from human salivary gland functional organoids for epithelial repair. Bioact Mater. 2022, 18, 151-163.  
80. Liang, Y.; Duan, L.; Lu, J.; Xia, J. Engineering exosomes for targeted drug delivery. Theranostics. 2021, 11, 3183-3195.  
81. Liang, Y.; Xu, X.; Li, X.; Xiong, J.; Li, B.; Duan, L.; Wang, D.; Xia, J. Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy. ACS Appl Mater Interfaces. 2020, 12, 36938-36947.  
82. Zou, J.; Shi, M.; Liu, X.; Jin, C.; Xing, X.; Qiu, L.; Tan, W. Aptamer-functionalized exosomes: elucidating the cellular uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem. 2019, 91, 2425-2430.  
83. Wen, M.; Wang, J.; Ou, Z.; Nie, G.; Chen, Y.; Li, M.; Wu, Z.; Xiong, S.; Zhou, H.; Yang, Z.; Long, G.; Su, J.; Liu, H.; Jing, Y.; Wen, Z.; Fu, Y.; Zhou, T.; Xie, H.; Guan, W.; Sun, X.; Wang, Z.; Wang, J.; Chen, X.; Jiang, L.; Qin, X.; Xue, Y.; Huang, M.; Huang, X.; Pan, R.; Zhen, H.; Du, Y.; Li, Q.; Huang, X.; Wu, Y.; Wang, P.; Zhao, K.; Situ, B.; Hu, X.; Zheng, L. Bacterial extracellular vesicles: A position paper by the microbial vesicles task force of the Chinese society for extracellular vesicles. Interdiscip Med. 2023, 1, e20230017.  
84. Lin, L.; Guo, Z.; He, E.; Long, X.; Wang, D.; Zhang, Y.; Guo, W.; Wei, Q.; He, W.; Wu, W.; Li, J.; Wo, L.; Hong, D.; Zheng, J.; He, M.; Zhao, Q. SIRT2 regulates extracellular vesicle-mediated liver-bone communication. Nat Metab. 2023, 5, 821-841.  
85. Wang, L.; Wang, D.; Ye, Z.; Xu, J. Engineering extracellular vesicles as delivery systems in therapeutic applications. Adv Sci (Weinh). 2023, 10, e2300552.  
86. Ji, N.; Wang, F.; Wang, M.; Zhang, W.; Liu, H.; Su, J. Engineered bacterial extracellular vesicles for central nervous system diseases. J Control Release. 2023, 364, 46-60.  
87. Lin, Y.; Wu, J.; Gu, W.; Huang, Y.; Tong, Z.; Huang, L.; Tan, J. Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs. Adv Sci (Weinh). 2018, 5, 1700611.  
88. Cui, Y.; Guo, Y.; Kong, L.; Shi, J.; Liu, P.; Li, R.; Geng, Y.; Gao, W.; Zhang, Z.; Fu, D. A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact Mater. 2022, 10, 207-221.  
89. Smyth, T.; Petrova, K.; Payton, N. M.; Persaud, I.; Redzic, J. S.; Graner, M. W.; Smith-Jones, P.; Anchordoquy, T. J. Surface functionalization of exosomes using click chemistry. Bioconjug Chem. 2014, 25, 1777-1784.  
90. Shi, Y.; Guo, S.; Liang, Y.; Liu, L.; Wang, A.; Sun, K.; Li, Y. Construction and evaluation of liraglutide delivery system based on milk exosomes: a new idea for oral peptide delivery. Curr Pharm Biotechnol. 2022, 23, 1072-1079.  
91. Cheng, K.; Zhao, R.; Li, Y.; Qi, Y.; Wang, Y.; Zhang, Y.; Qin, H.; Qin, Y.; Chen, L.; Li, C.; Liang, J.; Li, Y.; Xu, J.; Han, X.; Anderson, G. J.; Shi, J.; Ren, L.; Zhao, X.; Nie, G. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology. Nat Commun. 2021, 12, 2041.  
92. Li, Y.; Zhao, R.; Cheng, K.; Zhang, K.; Wang, Y.; Zhang, Y.; Li, Y.; Liu, G.; Xu, J.; Xu, J.; Anderson, G. J.; Shi, J.; Ren, L.; Zhao, X.; Nie, G. Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition. ACS Nano. 2020, 14, 16698-16711.  
93. Yang, Y.; Hong, Y.; Nam, G. H.; Chung, J. H.; Koh, E.; Kim, I. S. Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv Mater. 2017, 29, 1605604.  
94. Chatterjee, M.; Özdemir, S.; Kunadt, M.; Koel-Simmelink, M.; Boiten, W.; Piepkorn, L.; Pham, T. V.; Chiasserini, D.; Piersma, S. R.; Knol, J. C.; Möbius, W.; Mollenhauer, B.; van der Flier, W. M.; Jimenez, C. R.; Teunissen, C. E.; Jahn, O.; Schneider, A. C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer’s disease: A multi-cohort proteomics and immuno-assay validation study. Alzheimers Dement. 2023, 19, 4828-4840.  
95. Piffoux, M.; Silva, A. K. A.; Wilhelm, C.; Gazeau, F.; Tareste, D. Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems. ACS Nano. 2018, 12, 6830-6842.  
96. Chen, Q.; Huang, G.; Wu, W.; Wang, J.; Hu, J.; Mao, J.; Chu, P. K.; Bai, H.; Tang, G. A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination. Adv Mater. 2020, 32, e1908185.  
97. Yi, K.; Rong, Y.; Huang, L.; Tang, X.; Zhang, Q.; Wang, W.; Wu, J.; Wang, F. Aptamer-exosomes for tumor theranostics. ACS Sens. 2021, 6, 1418-1429.  

98. Sun, S.; Liu, H.; Hu, Y.; Wang, Y.; Zhao, M.; Yuan, Y.; Han, Y.; Jing, Y.; Cui, J.; Ren, X.; Chen, X.; Su, J. Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle. Bioact Mater. 2023, 20, 166-178.  
99. Haney, M. J.; Klyachko, N. L.; Zhao, Y.; Gupta, R.; Plotnikova, E. G.; He, Z.; Patel, T.; Piroyan, A.; Sokolsky, M.; Kabanov, A. V.; Batrakova, E. V. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015, 207, 18-30.  
100. Hajipour, H.; Farzadi, L.; Roshangar, L.; Latifi, Z.; Kahroba, H.; Shahnazi, V.; Hamdi, K.; Ghasemzadeh, A.; Fattahi, A.; Nouri, M. A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity. Life Sci. 2021, 275, 119351.  
101. Zha, Y.; Li, Y.; Lin, T.; Chen, J.; Zhang, S.; Wang, J. Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects. Theranostics. 2021, 11, 397-409.  
102. Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; Wood, M. J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011, 29, 341-345.  
103. Chen, C. Y.; Rao, S. S.; Yue, T.; Tan, Y. J.; Yin, H.; Chen, L. J.; Luo, M. J.; Wang, Z.; Wang, Y. Y.; Hong, C. G.; Qian, Y. X.; He, Z. H.; Liu, J. H.; Yang, F.; Huang, F. Y.; Tang, S. Y.; Xie, H. Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis. Sci Adv. 2022, 8, eabg8335.  
104. Liu, J. H.; Chen, C. Y.; Liu, Z. Z.; Luo, Z. W.; Rao, S. S.; Jin, L.; Wan, T. F.; Yue, T.; Tan, Y. J.; Yin, H.; Yang, F.; Huang, F. Y.; Guo, J.; Wang, Y. Y.; Xia, K.; Cao, J.; Wang, Z. X.; Hong, C. G.; Luo, M. J.; Hu, X. K.; Liu, Y. W.; Du, W.; Luo, J.; Hu, Y.; Zhang, Y.; Huang, J.; Li, H. M.; Wu, B.; Liu, H. M.; Chen, T. H.; Qian, Y. X.; Li, Y. Y.; Feng, S. K.; Chen, Y.; Qi, L. Y.; Xu, R.; Tang, S. Y.; Xie, H. Extracellular vesicles from child gut microbiota enter into bone to preserve bone mass and strength. Adv Sci (Weinh). 2021, 8, 2004831.  
105. Liu, H.; Wu, Y.; Wang, F.; Wang, S.; Ji, N.; Wang, M.; Zhou, G.; Han, R.; Liu, X.; Weng, W.; Tan, H.; Jing, Y.; Zhang, W.; Zhang, H.; Shi, Z.; Su, J. Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis. Compos B Eng. 2023, 267, 111047.  
106. Kalluri, R.; McAndrews, K. M. The role of extracellular vesicles in cancer. Cell. 2023, 186, 1610-1626.  
107. Eastlake, K.; Wang, W.; Jayaram, H.; Murray-Dunning, C.; Carr, A. J. F.; Ramsden, C. M.; Vugler, A.; Gore, K.; Clemo, N.; Stewart, M.; Coffey, P.; Khaw, P. T.; Limb, G. A. Phenotypic and functional characterization of Müller glia isolated from induced pluripotent stem cell-derived retinal organoids: improvement of retinal ganglion cell function upon transplantation. Stem Cells Transl Med. 2019, 8, 775-784.  
108. Eastlake, K.; Lamb, W. D. B.; Luis, J.; Khaw, P. T.; Jayaram, H.; Limb, G. A. Prospects for the application of Müller glia and their derivatives in retinal regenerative therapies. Prog Retin Eye Res. 2021, 85, 100970.  
109. Xu, X.; Song, J. Segmental long bone regeneration guided by degradable synthetic polymeric scaffolds. Biomater Transl. 2020, 1, 33-45.  
110. Yuan, G.; Li, Z.; Lin, X.; Li, N.; Xu, R. New perspective of skeletal stem cells. Biomater Transl. 2022, 3, 280-294.  
111. Arthur, P.; Kandoi, S.; Sun, L.; Kalvala, A.; Kutlehria, S.; Bhattacharya, S.; Kulkarni, T.; Nimma, R.; Li, Y.; Lamba, D. A.; Singh, M. Biophysical, molecular and proteomic profiling of human retinal organoid-derived exosomes. Pharm Res. 2023, 40, 801-816.  
112. Liu, C.; Helsper, S.; Marzano, M.; Chen, X.; Muok, L.; Esmonde, C.; Zeng, C.; Sun, L.; Grant, S. C.; Li, Y. Human forebrain organoid-derived extracellular vesicle labeling with iron oxides for in vitro magnetic resonance imaging. Biomedicines. 2022, 10, 3060.  
113. Wang, Y.; Chu, X.; Wang, B. Recombinant adeno-associated virus-based gene therapy combined with tissue engineering for musculoskeletal regenerative medicine. Biomater Transl. 2021, 2, 19-29.